301393 昊帆生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.3427.34730.26835.17630.980
总资产报酬率 ROA (%)1.2976.85724.29228.25024.969
投入资产回报率 ROIC (%)1.3327.24128.56133.29229.667

边际利润分析
销售毛利率 (%)38.03438.55343.25846.44346.822
营业利润率 (%)37.45428.95233.35334.95819.351
息税前利润/营业总收入 (%)22.23821.90732.39735.40921.059
净利润/营业总收入 (%)32.69625.45728.91230.15414.309

收益指标分析
经营活动净收益/利润总额(%)86.87197.99298.45798.71396.115
价值变动净收益/利润总额(%)0.8121.5410.2650.9151.674
营业外收支净额/利润总额(%)0.176-0.068-0.191-0.075-0.036

偿债能力分析
流动比率 (X)28.08029.8323.2263.4213.601
速动比率 (X)26.51928.0852.1882.4912.691
资产负债率 (%)3.4433.28319.62719.89419.400
带息债务/全部投入资本 (%)0.5100.1583.6004.1872.330
股东权益/带息债务 (%)19,446.23062,960.8562,631.5802,241.8454,110.054
股东权益/负债合计 (%)2,804.4992,946.103409.499402.652415.465
利息保障倍数 (X)-1.455-3.119-36.29674.12312.278

营运能力分析
应收账款周转天数 (天)65.95651.63047.03850.34847.898
存货周转天数 (天)179.238172.124136.362119.462125.693